European Journal of Breast Health · 2023 · 10 citations · 41 references
MedicineOncologyRadiation OncologyBreast OncologyBreast Radiation OncologyChemotherapyAdjuvant ChemotherapyAdjuvant TherapyBreast Cancer RadiotherapyHypofractionated Breast RadiotherapyRadiation TherapyRadiobiological ConsiderationsBreast Cancer ChemotherapyBreast Cancer FractionationBreast-conserving RadiotherapyDose De-intensificationLocal Disease ControlLong-term Side EffectsTreatment StrategiesTumor Profiling
Breast cancer stands as the most prevalent malignancy, necessitating a well-established approach to its management due to its sustained prevalence over decades. The implementation of intensive treatments, combining various modalities, has yielded excellent survival outcomes. Consequently, the optimization of quality of life and the mitigation of long-term side effects emerge as critical considerations for clinicians. As a result, discussions regarding treatment de-intensification strategies have been initiated for all treatment modalities, including surgery, radiotherapy (RT), and chemotherapy. RT plays a crucial role in adjuvant therapy. The efficacy of RT in disease control and overall survival across all stages of breast cancer has been demonstrated in numerous clinical trials and meta-analyses utilizing extensive datasets. However, advancements in genetic tumor profiling and improved identification of disease subgroups have prompted a reevaluation of RT omission in low-risk groups as a strategy for treatment de-intensification. Conversely, technological improvements and shortened total treatment times with hypofractionation make RT a secure and feasible option for enhancing local control and survival with minimal impact on the quality of life.
41
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine · 2013 · 4K citations · Full text
Medicine, Cardiology, Oncology +17
Kevin S. Hughes, Lauren A. Schnaper, Jennifer R. Bellon et al. · Journal of Clinical Oncology · 2013 · 1.3K citations · Full text